Literature DB >> 26096049

Lymphomatoid Granulomatosis with Central Nervous System Involvement Successfully Treated with Cyclophosphamide, High-dose Cytarabine, Dexamethasone, Etoposide, and Rituximab (CHASER therapy) Followed by Brain Irradiation: A Case Study.

Motoki Fujimaki1,2, Sumihiro Kawajiri1, Kunimoto Ichikawa3, Yuji Tomizawa1, Tomoko Nakazato1,2, Kazuyuki Noda1, Nobutaka Hattori2, Michiaki Koike3, Yasuyuki Okuma1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26096049      PMCID： PMC6495672          DOI： 10.1111/cns.12414

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN： 1755-5930            Impact factor:   5.243


× No keyword cloud information.
  3 in total

1.  Primary central nervous system lymphomatoid granulomatosis: a case report.

Authors:  Yuanyuan Xiang; Peng Yan; Shan Li; Yuan Xue; Cuicui Liu; Jifeng Li; Qinjian Sun; Yifeng Du; Xiaohui Liu
Journal:  Neurol Sci       Date:  2020-10-20       Impact factor: 3.307

2.  Use of rituximab in lymphomatoid granulomatosis with isolated central nervous system involvement.

Authors:  Jesse Mooneyham; Cesar Gentille; Andrea Barbieri; Shilpan Shah
Journal:  BMJ Case Rep       Date:  2020-09-07

Review 3.  Systematic Review of Spinal Lymphomatoid Granulomatosis Cases.

Authors:  Naotaka Iwamoto; Kyongsong Kim; Rinko Kokubo; Toyohiko Isu; Daijiro Morimoto; Tomoko Omura; Koji Saito; Yoshinao Kikuchi; Yasunori Ota; Akira Matsuno; Akio Morita
Journal:  World Neurosurg X       Date:  2021-04-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.